Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sarah Mühl

Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study

BMC Neurology

Medicine

Neurology

2017

English

Related publications

Seasonal Adherence To, and Effectiveness Of, Subcutaneous Interferon Β-1a Administered by RebiSmart® in Patients With Relapsing Multiple Sclerosis: Results of the 1-Year, Observational GEPAT-SMART Study

English

Adherence to Self-Administering Interferon-Β1a Using RebiSmart® Device in Mexican Patients With Relapsing Multiple Sclerosis

PLoS ONE

Multidisciplinary

2020

English

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis

Neurology

2011

English

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

English

Network Analysis of Transcriptional Regulation in Response to Intramuscular Interferon-Β-1a Multiple Sclerosis Treatment

Pharmacogenomics Journal

English

Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study

Journal of the Neurological Sciences

Neurology

2016

English

Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis

Intensive Care Medicine

2018

English

Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study

English

Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sarah Mühl

Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study

Related publications

Seasonal Adherence To, and Effectiveness Of, Subcutaneous Interferon Β-1a Administered by RebiSmart® in Patients With Relapsing Multiple Sclerosis: Results of the 1-Year, Observational GEPAT-SMART Study

Adherence to Self-Administering Interferon-Β1a Using RebiSmart® Device in Mexican Patients With Relapsing Multiple Sclerosis

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

Network Analysis of Transcriptional Regulation in Response to Intramuscular Interferon-Β-1a Multiple Sclerosis Treatment

Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study

Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis

Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study

Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil